ABBEYGAIL JIONGCO: Open Payments
NPI 1457990731 · EL CAJON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$807 in 37 payments from 12 companies in 2025. Trend: 2023 $1,532 · 2024 $1,129 · 2025 $807
Food & beverage: $807
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 6 | $155 |
| Novo Nordisk Inc | 6 | $134 |
| Janssen Pharmaceuticals, Inc | 4 | $103 |
| AstraZeneca Pharmaceuticals LP | 4 | $87 |
| Amgen Inc. | 4 | $84 |
| Lilly USA, LLC | 4 | $79 |
| Exact Sciences Corporation | 3 | $50 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| ABBVIE INC. | 1 | $22 |
Products named: SPRAVATO, Wegovy, OTEZLA, AIRSUPRA, JARDIANCE, Cologuard Collection Kit, NEXLETOL, Rybelsus.
Industry payments across CA — which companies pay providers there.
